• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.

作者信息

Winiszewski Hadrien, Rougny Anne-Claire, Lagoutte-Renosi Jennifer, Millon Laurence, Capellier Gilles, Navellou Jean-Christophe, Piton Gael, Clairet Anne-Laure

机构信息

Medical Intensive Care Unit, Besançon, France.

Research Unit EA 3920 and SFR FED 4234, University of Franche Comté, Besançon, France.

出版信息

Crit Care. 2018 Dec 22;22(1):355. doi: 10.1186/s13054-018-2285-5.

DOI:10.1186/s13054-018-2285-5
PMID:30577863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6303967/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a2/6303967/508bca0563b2/13054_2018_2285_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a2/6303967/508bca0563b2/13054_2018_2285_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7a2/6303967/508bca0563b2/13054_2018_2285_Fig1_HTML.jpg

相似文献

1
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.体外膜肺氧合辅助治疗并发严重流感的侵袭性曲霉病的药代动力学挑战。
Crit Care. 2018 Dec 22;22(1):355. doi: 10.1186/s13054-018-2285-5.
2
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.在 3 期 SECURE 和 VITAL 试验中，用伊曲康唑或伏立康唑治疗侵袭性曲霉病患者的 MIC 值结果。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01634-18. Print 2019 Jan.
3
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.三唑类药物治疗侵袭性曲霉病：一项为期三年的队列分析。
Mycoses. 2020 Jan;63(1):58-64. doi: 10.1111/myc.13013. Epub 2019 Oct 30.
4
Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.巴西患者侵袭性曲霉病的烟曲霉分离株中尚未出现三唑类耐药现象。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00608-17. Print 2017 Nov.
5
[Invasive aspergillosis in solid organ transplantation].[实体器官移植中的侵袭性曲霉病]
Rev Iberoam Micol. 2018 Oct-Dec;35(4):206-209. doi: 10.1016/j.riam.2018.05.002. Epub 2018 Nov 20.
6
[Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].[侵袭性真菌病的当前治疗选择及艾沙康唑的潜在治疗作用]
Rev Iberoam Micol. 2018 Oct-Dec;35(4):192-197. doi: 10.1016/j.riam.2018.07.003. Epub 2018 Nov 16.
7
New pharmacological opportunities for the treatment of invasive mould diseases.侵袭性霉菌病治疗的新药理学机遇
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i48-i58. doi: 10.1093/jac/dkx033.
8
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.瑞典伊曲康唑与伏立康唑治疗疑似侵袭性曲霉病患者的成本效果分析。
BMC Infect Dis. 2019 Feb 11;19(1):134. doi: 10.1186/s12879-019-3683-2.
9
Broad-spectrum azoles and flucloxacillin: a dangerous match.广谱唑类药物和氟氯西林：危险组合。
Eur J Clin Microbiol Infect Dis. 2022 Jan;41(1):153-154. doi: 10.1007/s10096-021-04333-z. Epub 2021 Sep 7.
10
Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.硫酸艾沙康唑：一种用于治疗侵袭性曲霉病和侵袭性毛霉病的新型药物。
Expert Rev Clin Pharmacol. 2016 Jul;9(7):887-97. doi: 10.1080/17512433.2016.1185361. Epub 2016 May 21.

引用本文的文献

1
A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation.体外膜肺氧合成人危重症患者的抗菌药物剂量：叙述性综述
Crit Care. 2024 Oct 4;28(1):326. doi: 10.1186/s13054-024-05101-z.
2
Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.危重症患者和体外膜肺氧合支持下伏立康唑的药代动力学：一项回顾性比较病例对照研究
Antibiotics (Basel). 2023 Jun 25;12(7):1100. doi: 10.3390/antibiotics12071100.
3
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.

本文引用的文献

1
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
2
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗：2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
3
Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.
体外膜肺氧合患者的抗真菌药物剂量。
Clin Pharmacokinet. 2023 Jul;62(7):931-942. doi: 10.1007/s40262-023-01264-0. Epub 2023 Jun 10.
4
Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study.体外膜肺氧合对伏立康唑血药浓度的影响：一项回顾性研究。
Front Pharmacol. 2022 Aug 17;13:972585. doi: 10.3389/fphar.2022.972585. eCollection 2022.
5
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.在接受体外膜氧合支持的成年患者中，治疗侵袭性曲霉菌病时伊曲康唑的谷浓度降低。
Am J Health Syst Pharm. 2022 Jul 22;79(15):1245-1249. doi: 10.1093/ajhp/zxac043.
6
A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗患者伏立康唑暴露情况的大型回顾性评估
Microorganisms. 2021 Jul 20;9(7):1543. doi: 10.3390/microorganisms9071543.
7
[Effect of extracorporeal membrane oxygenation on pharmacokinetics of antimicrobial drugs: recent progress and recommendations].[体外膜肺氧合对抗菌药物药代动力学的影响：最新进展与建议]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 May 20;41(5):793-800. doi: 10.12122/j.issn.1673-4254.2021.05.23.
8
Sequestration of Voriconazole and Vancomycin Into Contemporary Extracorporeal Membrane Oxygenation Circuits: An Study.伏立康唑和万古霉素在当代体外膜肺氧合回路中的潴留：一项研究
Front Pediatr. 2020 Aug 27;8:468. doi: 10.3389/fped.2020.00468. eCollection 2020.
体外膜肺氧合期间潜在的药物螯合作用：一项体外实验的结果
Intensive Care Med. 2007 Jun;33(6):1018-24. doi: 10.1007/s00134-007-0606-2. Epub 2007 Apr 3.